Fig. 7From: How to schedule VEGF and PD-1 inhibitors in combination cancer therapy?Spatial profiles of the densities of dendritic cells, T cells, endothelial cells and cancer cells with γA=1.2×10−10g/cm3·day,γB=9.5×10−9g/cm3·day. a Profiles under schedule S2 at day t=0,8,15 and 16 weeks. b Profiles under schedule S3 at days t=0,8,18 and 19 weeksBack to article page